Titre : Criminels

Criminels : Questions médicales fréquentes

Termes MeSH sélectionnés :

Gene Expression Profiling
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Criminels : Questions médicales les plus fréquentes", "headline": "Criminels : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Criminels : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-23", "dateModified": "2025-04-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Criminels" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Personnes", "url": "https://questionsmedicales.fr/mesh/D009272", "about": { "@type": "MedicalCondition", "name": "Personnes", "code": { "@type": "MedicalCode", "code": "D009272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "M01" } } }, "about": { "@type": "MedicalCondition", "name": "Criminels", "alternateName": "Criminals", "code": { "@type": "MedicalCode", "code": "D057237", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ian Freckelton", "url": "https://questionsmedicales.fr/author/Ian%20Freckelton", "affiliation": { "@type": "Organization", "name": "Barrister, Crockett Chambers, Melbourne; Professorial Fellow of Law and Psychiatry, University of Melbourne; Adjunct Professor of Forensic Medicine, Monash University. Adjunct Professor, Johns Hopkins University, Baltimore, USA." } }, { "@type": "Person", "name": "Alexander McClelland", "url": "https://questionsmedicales.fr/author/Alexander%20McClelland", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Colleen M Berryessa", "url": "https://questionsmedicales.fr/author/Colleen%20M%20Berryessa", "affiliation": { "@type": "Organization", "name": "School of Criminal Justice, Rutgers University." } }, { "@type": "Person", "name": "Kenneth J Weiss", "url": "https://questionsmedicales.fr/author/Kenneth%20J%20Weiss", "affiliation": { "@type": "Organization", "name": "Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA." } }, { "@type": "Person", "name": "Shichun Ling", "url": "https://questionsmedicales.fr/author/Shichun%20Ling", "affiliation": { "@type": "Organization", "name": "Department of Criminology, University of Pennsylvania, Philadelphia, PA 19104, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Aberrant Gene Expression Profiling in Men With Sertoli Cell-Only Syndrome.", "datePublished": "2022-06-27", "url": "https://questionsmedicales.fr/article/35833143", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.821010" } }, { "@type": "ScholarlyArticle", "name": "Genome-wide identification and expression profiling of sugar transporter genes in tobacco.", "datePublished": "2022-06-14", "url": "https://questionsmedicales.fr/article/35714802", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.gene.2022.146652" } }, { "@type": "ScholarlyArticle", "name": "Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.", "datePublished": "2023-08-02", "url": "https://questionsmedicales.fr/article/37533202", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cam4.6411" } }, { "@type": "ScholarlyArticle", "name": "The NeuroinflammatoryPotential of HIV-1 NefVariants in Modulating the Gene Expression Profile of Astrocytes.", "datePublished": "2022-10-17", "url": "https://questionsmedicales.fr/article/36291123", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cells11203256" } }, { "@type": "ScholarlyArticle", "name": "Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression.", "datePublished": "2022-06-30", "url": "https://questionsmedicales.fr/article/35771282", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00401-022-02460-1" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Personnes", "item": "https://questionsmedicales.fr/mesh/D009272" }, { "@type": "ListItem", "position": 3, "name": "Criminels", "item": "https://questionsmedicales.fr/mesh/D057237" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Criminels - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Criminels", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Criminels", "description": "Comment diagnostiquer un comportement criminel ?\nQuels tests sont utilisés pour évaluer les criminels ?\nLes criminels ont-ils des troubles mentaux ?\nComment évaluer le risque de récidive ?\nQuelles sont les caractéristiques des criminels violents ?", "url": "https://questionsmedicales.fr/mesh/D057237?mesh_terms=Gene+Expression+Profiling&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Criminels", "description": "Quels symptômes peuvent indiquer un comportement criminel ?\nLes criminels ressentent-ils de la culpabilité ?\nComment la colère se manifeste-t-elle chez les criminels ?\nLes criminels présentent-ils des signes de dépression ?\nQuels comportements sont souvent associés à la criminalité ?", "url": "https://questionsmedicales.fr/mesh/D057237?mesh_terms=Gene+Expression+Profiling&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Criminels", "description": "Comment prévenir la criminalité chez les jeunes ?\nQuel rôle joue la famille dans la prévention ?\nLes interventions communautaires sont-elles efficaces ?\nComment l'éducation peut-elle prévenir la criminalité ?\nLes programmes de mentorat sont-ils bénéfiques ?", "url": "https://questionsmedicales.fr/mesh/D057237?mesh_terms=Gene+Expression+Profiling&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Criminels", "description": "Quels traitements sont disponibles pour les criminels ?\nLa réhabilitation est-elle efficace pour les criminels ?\nComment la thérapie de groupe aide-t-elle les criminels ?\nLes médicaments peuvent-ils réduire la violence ?\nQuelles approches sont utilisées pour traiter les criminels ?", "url": "https://questionsmedicales.fr/mesh/D057237?mesh_terms=Gene+Expression+Profiling&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Criminels", "description": "Quelles complications peuvent résulter de la criminalité ?\nComment la criminalité affecte-t-elle la santé mentale ?\nLes victimes de crimes souffrent-elles de complications ?\nQuels impacts sociaux la criminalité engendre-t-elle ?\nLa stigmatisation des criminels a-t-elle des conséquences ?", "url": "https://questionsmedicales.fr/mesh/D057237?mesh_terms=Gene+Expression+Profiling&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Criminels", "description": "Quels sont les facteurs de risque de la criminalité ?\nLe manque d'éducation est-il un facteur de risque ?\nLes antécédents familiaux influencent-ils la criminalité ?\nL'usage de drogues est-il un facteur de risque ?\nLes troubles mentaux augmentent-ils le risque criminel ?", "url": "https://questionsmedicales.fr/mesh/D057237?mesh_terms=Gene+Expression+Profiling&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un comportement criminel ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation psychologique et l'historique criminel." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les criminels ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests psychométriques et des entretiens cliniques sont souvent utilisés." } }, { "@type": "Question", "name": "Les criminels ont-ils des troubles mentaux ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreux criminels présentent des troubles mentaux, mais ce n'est pas systématique." } }, { "@type": "Question", "name": "Comment évaluer le risque de récidive ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des outils d'évaluation du risque, comme le HCR-20, sont utilisés pour prédire la récidive." } }, { "@type": "Question", "name": "Quelles sont les caractéristiques des criminels violents ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent présenter des traits de personnalité antisociale et des antécédents de violence." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un comportement criminel ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des comportements impulsifs, une absence d'empathie et des violations des règles sociales." } }, { "@type": "Question", "name": "Les criminels ressentent-ils de la culpabilité ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Certains criminels peuvent éprouver peu ou pas de culpabilité pour leurs actes." } }, { "@type": "Question", "name": "Comment la colère se manifeste-t-elle chez les criminels ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "La colère peut se manifester par des explosions de violence ou des comportements destructeurs." } }, { "@type": "Question", "name": "Les criminels présentent-ils des signes de dépression ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains peuvent souffrir de dépression, mais cela varie selon l'individu." } }, { "@type": "Question", "name": "Quels comportements sont souvent associés à la criminalité ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "L'usage de drogues, l'alcoolisme et des comportements à risque sont fréquents." } }, { "@type": "Question", "name": "Comment prévenir la criminalité chez les jeunes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes éducatifs et des activités de loisirs peuvent réduire le risque de criminalité." } }, { "@type": "Question", "name": "Quel rôle joue la famille dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une famille stable et engagée peut réduire le risque de comportements criminels chez les enfants." } }, { "@type": "Question", "name": "Les interventions communautaires sont-elles efficaces ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent renforcer les liens sociaux et réduire la criminalité dans les quartiers." } }, { "@type": "Question", "name": "Comment l'éducation peut-elle prévenir la criminalité ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation améliore les opportunités et réduit les comportements à risque chez les jeunes." } }, { "@type": "Question", "name": "Les programmes de mentorat sont-ils bénéfiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils offrent des modèles positifs et des conseils aux jeunes à risque." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les criminels ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie cognitivo-comportementale et la médication." } }, { "@type": "Question", "name": "La réhabilitation est-elle efficace pour les criminels ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la réhabilitation peut réduire le risque de récidive si elle est bien conçue." } }, { "@type": "Question", "name": "Comment la thérapie de groupe aide-t-elle les criminels ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Elle favorise le partage d'expériences et l'apprentissage de comportements prosociaux." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils réduire la violence ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments, comme les stabilisateurs de l'humeur, peuvent aider à réduire la violence." } }, { "@type": "Question", "name": "Quelles approches sont utilisées pour traiter les criminels ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les approches incluent la thérapie individuelle, la thérapie de groupe et la médication." } }, { "@type": "Question", "name": "Quelles complications peuvent résulter de la criminalité ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des traumatismes physiques, des problèmes juridiques et des troubles mentaux." } }, { "@type": "Question", "name": "Comment la criminalité affecte-t-elle la santé mentale ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des troubles anxieux, dépressifs et des troubles de stress post-traumatique." } }, { "@type": "Question", "name": "Les victimes de crimes souffrent-elles de complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent souffrir de traumatismes psychologiques et de problèmes de santé physique." } }, { "@type": "Question", "name": "Quels impacts sociaux la criminalité engendre-t-elle ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La criminalité peut déstabiliser les communautés et engendrer la peur et la méfiance." } }, { "@type": "Question", "name": "La stigmatisation des criminels a-t-elle des conséquences ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraver la réhabilitation et augmenter le risque de récidive." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de la criminalité ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'environnement socio-économique, l'éducation et les antécédents familiaux." } }, { "@type": "Question", "name": "Le manque d'éducation est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un faible niveau d'éducation est souvent associé à un risque accru de criminalité." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils la criminalité ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents criminels dans la famille augmentent le risque chez les enfants." } }, { "@type": "Question", "name": "L'usage de drogues est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'usage de drogues est souvent lié à des comportements criminels et à la violence." } }, { "@type": "Question", "name": "Les troubles mentaux augmentent-ils le risque criminel ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certains troubles mentaux peuvent augmenter le risque de comportements criminels, mais pas tous." } } ] } ] }

Sources (10000 au total)

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.

Pancreatic ductal adenocarcinoma (PDAC) has the lowest survival rate of all major cancers. Chemotherapy is the mainstay systemic therapy for PDAC, and chemoresistance is a major clinical problem leadi... Archived formalin-fixed paraffin-embedded tumor tissue samples from patients treated with neoadjuvant chemotherapy were obtained during surgical resection. Specimens were macrodissected and gene expre... Initially, unsupervised multivariate modeling was performed by principal component analysis, which demonstrated a distinct gene expression profile between good- and poor-chemotherapy responders. There... A distinct tumor biological profile between PDAC patients who either respond or not respond to chemotherapy was identified....

Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.

To identify differentially expressed genes in temporal artery biopsies (TABs) from patients with giant cell arteritis (GCA) with different histological patterns of inflammation: transmural inflammatio... Expression of 770 immune-related genes was profiled with the NanoString nCounter PanCancer Immune Profiling Panel on formalin-fixed paraffin-embedded TABs from 42 GCA patients with TMI, 7 GCA patients... Unsupervised clustering of the samples revealed two distinct groups: normal TABs and TABs with ILA in one group, 41/42 TABs with TMI in the other one. TABs with TMI showed 31 downregulated and 256 upr... TABs with TMI had a distinct transcriptome compared with normal TABs and TABs with ILA. The few genes potentially deregulated in ILA were also deregulated in TMI. Gene profiling allowed to deepen the ...

Identification and Validation of Common Reference Genes for Normalization of Esophageal Squamous Cell Carcinoma Gene Expression Profiles.

Esophageal squamous cell carcinoma (ESCC) is one of the subtypes of esophageal cancer with Chinese characteristics, and its five-year survival rate is less than 20%. Early diagnosis is beneficial to i...

Identification and Validation of Autophagy-Related Genes in Primary Ovarian Insufficiency by Gene Expression Profile and Bioinformatic Analysis.

To investigate the relationship between primary ovarian insufficiency and autophagy, we detected and got the expression profile of human granulosa cell line SVOG, which was with or without LPS induced... Totally, 6 genes were selected as candidate hub genes which might correlate with the process of primary ovarian insufficiency. The expression of hub genes was then validated by quantitative real-time ... The results indicated that autophagy might play an essential role in the process and underlying molecular mechanism of primary ovarian insufficiency, which was revealed for the first time and may help...

Intralesional gene expression profile of JAK-STAT signaling pathway and associated cytokines in

The JAK-STAT signaling pathway is a central cascade of signal transduction for the myriad of cytokines in which dysregulation has been implicated in progression of inflammatory and infectious diseases... This study sought to investigate differential gene expression of several cytokines and their associated... Results showed that the gene expression levelsof both Th1 (... Our finding revealed dysregulation of cytokines and related...

Identification and gene expression profiling of human gonadotrophic pituitary adenoma stem cells.

Gonadotrophic pituitary adenoma is a major subtype of pituitary adenoma in the sellar region, but it is rarely involved in the hypersecretion of hormones into blood; thus, it is commonly regarded as "... The hPASCs from 14 human gonadotrophic pituitary adenoma clinical samples were cultured and verified via immunohistochemistry. Genetic profiling of hPASCs and the matched tumor cells was performed thr... The hPASCs were successfully isolated and cultured from gonadotrophic pituitary adenoma in vitro, which were identified as positive for generic stem cell markers (Sox2, Oct4, Nestin and CD133) via imm... Genetic profiling of hPASCs may explain the tumorigenesis and invasiveness of gonadotrophic pituitary adenoma. ANXA2 may serve as a potential therapeutic target for the treatment of gonadotrophic pitu...